Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 05:50PM
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 29, 2022 10:06AM
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 11:11AM
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 05:27PM
|
Re: COVID 19 - Standard of Care
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 07:51PM
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:36PM
|
Re: Courtesy
|
2
|
Resverlogix Corp.
|
Aug 19, 2017 01:17PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 11:55AM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
2
|
Resverlogix Corp.
|
Dec 13, 2021 12:46PM
|
Re: Conspiracies of sorts
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 10:52AM
|
Re: Consequences of BETonMACE Findings
|
5
|
Resverlogix Corp.
|
May 11, 2016 03:50PM
|
Re: Consequences of BETonMACE Findings
|
3
|
Resverlogix Corp.
|
May 10, 2016 04:07PM
|
Re: Congrats
|
1
|
Resverlogix Corp.
|
Jul 25, 2017 12:42PM
|
Re: Confused
|
2
|
Zenith Epigenetics
|
Dec 20, 2015 10:53AM
|
Re: Confused
|
2
|
Zenith Epigenetics
|
Dec 19, 2015 11:06AM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 12:25PM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 02:44PM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 03:29PM
|
Re: Compounds and Autoimmune
|
3
|
Resverlogix Corp.
|
Jun 21, 2016 05:23PM
|
Re: Compensation Commity
|
5
|
Resverlogix Corp.
|
Mar 28, 2021 12:13PM
|